The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-Methyl-2-(2-methylallyl)-2H-1,2,3-triazol-4-yl)-7Hpyrrolo[2,3-d]pyrimidine ID: ALA4474787
PubChem CID: 142744367
Max Phase: Preclinical
Molecular Formula: C13H14N6
Molecular Weight: 254.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=C(C)Cn1nc(C)c(-c2ncnc3[nH]ccc23)n1
Standard InChI: InChI=1S/C13H14N6/c1-8(2)6-19-17-9(3)11(18-19)12-10-4-5-14-13(10)16-7-15-12/h4-5,7H,1,6H2,2-3H3,(H,14,15,16)
Standard InChI Key: AGVBYMJWMOKXLR-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
10.1393 -11.5137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8520 -11.9129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5532 -11.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5459 -10.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8333 -10.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1279 -10.6966 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3351 -11.7390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3183 -10.4168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8068 -11.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2148 -8.2007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3977 -8.2121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1537 -8.9900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8219 -9.4616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4759 -8.9731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9092 -7.5540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2335 -6.8046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7408 -6.1505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0421 -6.7092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2579 -9.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
8 9 2 0
7 9 1 0
3 7 1 0
4 8 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
10 14 2 0
15 16 1 0
16 17 2 0
16 18 1 0
11 15 1 0
14 19 1 0
5 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 254.30Molecular Weight (Monoisotopic): 254.1280AlogP: 2.10#Rotatable Bonds: 3Polar Surface Area: 72.28Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.67CX Basic pKa: 0.82CX LogP: 1.79CX LogD: 1.79Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.73Np Likeness Score: -0.75
References 1. Lee SM, Yoon KB, Lee HJ, Kim J, Chung YK, Cho WJ, Mukai C, Choi S, Kang KW, Han SY, Ko H, Kim YC.. (2016) The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3., 24 (21): [PMID:27555284 ] [10.1016/j.bmc.2016.08.008 ]